Plain-English translation of NCT06195865 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two different surgical approaches to breast reconstruction after mastectomy. Some patients will be randomly assigned to either implant-based reconstruction or autologous reconstruction (using your own abdominal tissue, called a DIEP flap), while others with a strong preference can choose their preferred method. The study will follow you for five years to see which approach gives better satisfaction and quality of life.
While breast reconstruction is an important part of breast cancer treatment, doctors don't yet have clear evidence about which surgical method works best for most patients. This trial aims to gather that evidence so future patients and their doctors can make better-informed decisions.
You likely qualify if…
You likely don't qualify if…
If you join, you will either be randomly assigned to one of the two reconstruction methods or, if you have a strong preference, choose which method you'd like. You'll then receive your chosen surgery and be followed by the research team for 60 months (5 years). During this time, you'll complete surveys about your satisfaction and quality of life, report any complications, and participate in follow-up visits to monitor your healing and outcomes.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Sweden
Sponsor
Vastra Gotaland Region
Collaborators
Göteborg University
Enrollment target
~250 participants
Started
April 2024
Primary completion
December 2028
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Emma Hansson, PhD
Vastra Gotaland Region
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.